Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells

R. A. Mandanas, D. S. Leibowitz, K. Gharehbaghl, T. Tauchi, G. S. Burgess, K. Miyazawa, Hiremagalur Jayaram, H. S. Boswell

Research output: Contribution to journalArticle

156 Scopus citations

Abstract

The p21 RAS product has been implicated as part of the downstream signaling of certain nonreceptor tyrosine kinase oncogenes and several growth factor receptor-ligand interactions. We have reported that the chronic myelogenous leukemia oncogene p210 bcr-abl transforms a growth-factor- dependent myeloid cell line NFS/N1.H7 to interleukin-3 (IL-3) independence. In these p210 bcr-abl-transformed cells (H7 bcr-abl.A54) and in two other murine myeloid cell lines transformed to IL-3 independence by p210 bcr-abl, endogenous p21 RAS is activated as determined by an elevated ratio of associated guanosine triphosphate (GTP)/guanosine diphosphate (GDP), assayed by thin-layer chromatography of the nucleotides eluted from p21 RAS after immunoprecipitation with the Y13-259 antibody. Treatment of p210 bcr-abl- transformed cells with a specific tyrosine kinase inhibitor herbimycin A resulted in diminished tyrosine phosphorylation of p210 bcr-abl and associated proteins, without major reduction in expression of the p210 bcr- abl protein itself. Inhibition of p210 bcr-abl-dependent tyrosine phosphorylation resulted in a reduction of active p21RAS-GTP complexes in the transformed cells, in diminished expression of the nuclear early response genes c-jun and c-fos, and in lower cellular proliferation rate. To further implicate p21 RAS in these functional events downstream of p210 bcr-abl tyrosine phosphorylation, we targeted G-protein function directly by limiting the availability of GTP with the inosine monophosphate dehydrogenase inhibitor, tiazofurin (TR). In p210 bcr-abl-transformed cells treated for 4 hours with TR, in which the levels of GTP were reduced by 50%, but GDP, guanosine monophosphate, and adenosine triphosphate (ATP) were unaffected, p210 bcr-abl tyrosine phosphorylation was at control levels. However, expression of c-fos and c-jun nuclear proto-oncogenes were strongly inhibited and p21 RAS activity was downregulated. These findings show that p210 bcr- abl transduces proliferative signals, in part, through downstream activation of p21 RAS. Furthermore, p21 RAS activity is linked to pathways that regulate c-jun and c-fos expression.

Original languageEnglish (US)
Pages (from-to)1838-1847
Number of pages10
JournalBlood
Volume82
Issue number6
DOIs
StatePublished - 1993

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells'. Together they form a unique fingerprint.

  • Cite this

    Mandanas, R. A., Leibowitz, D. S., Gharehbaghl, K., Tauchi, T., Burgess, G. S., Miyazawa, K., Jayaram, H., & Boswell, H. S. (1993). Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells. Blood, 82(6), 1838-1847. https://doi.org/10.1182/blood.v82.6.1838.bloodjournal8261838